BON NATURAL LIFE LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.61 USD | -1.88% |
|
-6.12% | -51.67% |
Valuation
| Fiscal Period: September | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 67.76 | 18.16 | 4.492 |
| Enterprise Value (EV) 1 | 67.46 | 22.72 | 8.582 |
| P/E ratio | 12.5 x | 2.92 x | 0.81 x |
| Yield | - | - | - |
| Capitalization / Revenue | 2.66 x | 0.61 x | 0.15 x |
| EV / Revenue | 2.65 x | 0.76 x | 0.29 x |
| EV / EBITDA | 12 x | 3.36 x | 1.25 x |
| EV / FCF | -22,287,854 x | -3,704,885 x | -4,498,219 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 2.71 x | 0.61 x | 0.13 x |
| Nbr of stocks (in thousands) | 800 | 840 | 1,115 |
| Reference price 2 | 84.70 | 21.62 | 4.030 |
| Announcement Date | 1/31/22 | 2/10/23 | 2/9/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 10.78 | 16.4 | 18.22 | 25.49 | 29.91 | 29.52 |
| EBITDA 1 | 0.8262 | 3.402 | 3.699 | 5.629 | 6.759 | 6.873 |
| EBIT 1 | 0.6021 | 3.175 | 3.468 | 5.401 | 6.54 | 5.919 |
| Operating Margin | 5.58% | 19.37% | 19.03% | 21.18% | 21.87% | 20.05% |
| Earnings before Tax (EBT) 1 | 0.4057 | 2.99 | 3.655 | 5.43 | 7.509 | 5.555 |
| Net income 1 | 0.2234 | 2.574 | 3.027 | 4.591 | 6.237 | 4.596 |
| Net margin | 2.07% | 15.7% | 16.61% | 18.01% | 20.86% | 15.57% |
| EPS 2 | 0.4323 | 4.982 | 5.809 | 6.800 | 7.400 | 5.000 |
| Free Cash Flow | - | -0.724 | -3.545 | -3.027 | -6.133 | -1.908 |
| FCF margin | - | -4.42% | -19.46% | -11.87% | -20.51% | -6.46% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/7/20 | 12/7/20 | 3/30/21 | 1/31/22 | 2/10/23 | 2/9/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2023 S1 | 2023 S2 |
|---|---|---|
| Net sales 1 | 14.15 | 15.37 |
| EBITDA | - | - |
| EBIT | - | - |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | - | - |
| Net margin | - | - |
| EPS 2 | 2.400 | 2.600 |
| Dividend per Share | - | - |
| Announcement Date | 9/11/23 | 2/9/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 6.24 | 6.97 | 7.99 | - | 4.57 | 4.09 |
| Net Cash position 1 | - | - | - | 0.3 | - | - |
| Leverage (Debt/EBITDA) | 7.557 x | 2.048 x | 2.161 x | - | 0.6756 x | 0.5951 x |
| Free Cash Flow | - | -0.72 | -3.55 | -3.03 | -6.13 | -1.91 |
| ROE (net income / shareholders' equity) | - | 43.4% | 33.9% | 24.5% | 22% | 13.8% |
| ROA (Net income/ Total Assets) | - | 11% | 9.68% | 11% | 11.1% | 8.83% |
| Assets 1 | - | 23.48 | 31.25 | 41.9 | 56.21 | 52.07 |
| Book Value Per Share 2 | 8.800 | 13.20 | 18.10 | 31.20 | 35.20 | 30.20 |
| Cash Flow per Share 2 | 1.590 | 0.5700 | 0.0900 | 2.290 | 1.000 | 0.1000 |
| Capex 1 | 1.68 | 7.07 | 4.33 | 4.48 | 4.74 | 0.52 |
| Capex / Sales | 15.62% | 43.15% | 23.78% | 17.59% | 15.83% | 1.77% |
| Announcement Date | 12/7/20 | 12/7/20 | 3/30/21 | 1/31/22 | 2/10/23 | 2/9/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -51.67% | 3.71M | |
| +32.11% | 694B | |
| +29.39% | 593B | |
| -1.36% | 371B | |
| +20.18% | 331B | |
| +7.31% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.39% | 169B |
- Stock Market
- Equities
- BON Stock
- Financials Bon Natural Life Limited
